NCT04926714

Brief Summary

The aim of this study was to investigate the pathogenic role of obesity on blinding eye diseases in a population of severely obese patients with no history of eye diseases, and to verify whether weight loss induced by bariatric surgery may have a protective effect.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 17, 2021

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

June 10, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 15, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

June 23, 2021

Status Verified

June 1, 2021

Enrollment Period

2 years

First QC Date

June 10, 2021

Last Update Submit

June 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • optical coherence tomography

    12 months

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1. Patients with BMI≥32.5Kg/m2Or patients with BMI27.5-32.5Kg/m2, combined with metabolic diseases; 2. Subjects understand the purpose of the clinical study and are willing, able and committed to return to the study center for all clinical study visits and to complete all study procedures.

You may qualify if:

  • Patients with BMI≥32.5Kg/m2;
  • patients with BMI27.5-32.5Kg/m2, combined with metabolic diseases;

You may not qualify if:

  • Patients with pre-existing ocular diseases or visual alterations were excluded to avoid confounding factors related to pre-existing retinal pathology, independent from obesity per se.
  • Patients with dementia, Parkinson's disease, Alzheimer's disease, multiple sclerosis or other severe neurological diseases were also excluded since ophthalmologic parameters may be altered in these conditions.
  • Patients with lens opacities that made impossible the posterior segment examination, or with a refractive error \> +5 or \<-8 diopters spherical equivalent were also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Jinan University

Guangzhou, Guangdong, 510630, China

RECRUITING

MeSH Terms

Conditions

Eye Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Deputy chief physician of opthalmology, The First Affiliated Hospital of Jinan University

Study Record Dates

First Submitted

June 10, 2021

First Posted

June 15, 2021

Study Start

May 17, 2021

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

June 23, 2021

Record last verified: 2021-06

Locations